MediClin Fachklinik Rhein News and Activities

MediClin Fachklinik Rhein is owned by MediClin.

MediClin is a company listed under the stock ticker MED (DE).

They are in:

• Healthcare50%
• Biotechnology50%

View the org chart displaying its 3 main executives

Most searched biographies at MediClin Fachklinik Rhein

• Sebastian Klute, Commercial Director and Managing Director
• Roger Marx, Chief Clinical Officer, Cardiology
• Mario Siebler, Chief Clinical Officer, Neurology

Create your alert
to follow the executive moves at MediClin Fachklinik Rhein.

MediClin has 2,405 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Ona Therapeutics has just announced a $87 Million fundraising (posted on June 5 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Carl Gordon - Director at Odyssey Therapeutics

Learn more about the Biotechnology industry

Press releases by MediClin Fachklinik Rhein

Social media about MediClin Fachklinik Rhein

• MediClin Fachklinik Rhein on Wikipedia, Google News & Yahoo Finance
• MediClin Fachklinik Rhein on LinkedIn, X (Twitter) & YouTube